Section II
451 – 460 of 8708
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Pulmonary Hypertension Phenotype Can Be Identified in Heart Failure With Reduced Ejection Fraction Using Echocardiographic Assessment of Pulmonary Artery Pressure With Supportive Use of Pressure Reflection Variables
(
- Contribution to journal › Article
-
Mark
Regulatory B-cells are reduced in the blood in patients with granulomatosis with polyangiitis, and fail to regulate T-cell IFN-γ production
(
- Contribution to journal › Article
-
Mark
Prognostic Value of Early Sustained Ventricular Arrhythmias in ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention : A Substudy of VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
-
Mark
Conservative Management First Strategy in Aortic Vascular Graft and Endograft Infections
(
- Contribution to journal › Article
-
Mark
Splenic contraction and cardiovascular responses are augmented during apnea compared to rebreathing in humans
(
- Contribution to journal › Article
-
Mark
Incidence, aetiology and temporal trend of bloodstream infections in southern Sweden from 2006 to 2019 : a population-based study
2023) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 28(10). p.1-10(
- Contribution to journal › Article
-
Mark
Protocolised reduction of non-resuscitation fluids versus usual care in patients with septic shock (REDUSE) : a protocol for a multicentre feasibility trial
(
- Contribution to journal › Article
-
Mark
The precision of ROTEM EXTEM is decreased in hypocoagulable blood : a prospective observational study
(
- Contribution to journal › Article
-
Mark
Machine learning for early prediction of acute myocardial infarction or death in acute chest pain patients using electrocardiogram and blood tests at presentation
(
- Contribution to journal › Article
-
Mark
Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial) : Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial
(
- Contribution to journal › Article